Crinetics shareholders elect directors, ratify auditor, approve say-on-pay at annual meeting

Crinetics Pharmaceuticals, Inc.

Elected Class I directors R. Scott Struthers (69.6M for), Matthew K. Fust (67.6M for), and Rogério Vivaldi Coelho (68.9M for), each with ~3.6M broker non-votes.
Ratified BDO USA as independent auditor for FY2025: 88.7M for, 129K against, 59.7K abstentions, no broker non-votes.
Advisory vote approved named executive officer compensation: 82.7M for, 2.6M against, 20.9K abstentions, ~3.6M broker non-votes.
Approximately 95% of outstanding shares (88.9M shares) were present or represented by proxy.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.